Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.
about
Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirusKSHV-Mediated Angiogenesis in Tumor ProgressionHaploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligasesDiscrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expressionIntracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components.Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes.Quantitative membrane proteomics reveals new cellular targets of viral immune modulatorsEndothelial cells support persistent gammaherpesvirus 68 infection.The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherinKaposi's sarcoma-associated herpesvirus K3 and K5 proteins block distinct steps in transendothelial migration of effector memory CD4+ T cells by targeting different endothelial proteins.Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replicationMARCH-IX mediates ubiquitination and downregulation of ICAM-1.Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins down regulate both DC-SIGN and DC-SIGNR.Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.The specificities of Kaposi's sarcoma-associated herpesvirus-encoded E3 ubiquitin ligases are determined by the positions of lysine or cysteine residues within the intracytoplasmic domains of their targets.Viral and cellular MARCH ubiquitin ligases and cancer.At the crossroads of homoeostasis and disease: roles of the PACS proteins in membrane traffic and apoptosis.Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1).What has the study of the K3 and K5 viral ubiquitin E3 ligases taught us about ubiquitin-mediated receptor regulation?The Kaposi's sarcoma-associated herpesvirus K5 E3 ubiquitin ligase modulates targets by multiple molecular mechanisms.Newly discovered viral E3 ligase pK3 induces endoplasmic reticulum-associated degradation of class I major histocompatibility proteins and their membrane-bound chaperonesAntigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation.Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.The Role of F-Box Proteins during Viral Infection.HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers major histocompatibility complex class I (MHC-I) down-regulation: analysis using short interfering RNA and knock-out mice.Viral proteomics: global evaluation of viruses and their interaction with the host.Viral avoidance and exploitation of the ubiquitin system.p120-catenin regulates VE-cadherin endocytosis and degradation induced by the Kaposi sarcoma-associated ubiquitin ligase K5.Viral takeover of the host ubiquitin system.The Ubiquitin System and Kaposi's Sarcoma-Associated Herpesvirus.Instigation of Notch signaling in the pathogenesis of Kaposi's sarcoma-associated herpesvirus and other human tumor viruses.Cytomegalovirus immune evasion by perturbation of endosomal trafficking.KSHV downregulation of galectin-3 in Kaposi's sarcoma.Immune control of oncogenic γ-herpesviruses.Proliferation status defines functional properties of endothelial cells.The Membrane Associated RING-CH Proteins: A Family of E3 Ligases with Diverse Roles through the Cell.Caught in the act - protein adaptation and the expanding roles of the PACS proteins in tissue homeostasis and disease.Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone.
P2860
Q24650331-77BE4DC1-6331-42CA-ADF6-AB95E2AEFA22Q26742030-84F4ECB5-964D-4185-AE4F-79E564186DC7Q28535346-549EB5EA-D73D-4869-BB0A-C81D4E1AD972Q28589598-6DD4FEDE-644C-400D-B86B-CBB1DF2CF4C4Q28757509-810072FE-C77E-4010-BD2F-568F2D9BFDE3Q30439948-5C988C9B-EB99-45F0-80CE-31B8209834BBQ30993115-41BC131B-417E-403A-BF42-0B74D7A3A41CQ33269787-50F0E1EE-C787-45FE-866F-03295EBEA643Q33369078-357AC99D-1575-4936-B1A2-B06B033A5D46Q33564429-FD69C12A-234D-4AB7-AFB4-A2625A8D0CA7Q33882749-B0AE7840-7BFB-4847-BD54-FA0A58D5314AQ34059252-DEF1C82D-896D-424E-9C41-2376F972D8A3Q34591916-F623EFD9-9096-4FE9-B4E3-696F1A6F2504Q34608923-56EDD2AA-5E56-4282-8A90-B5053D17F50AQ34615002-BA703905-D1B0-4D3D-9DC7-82EFCA15FF26Q34644229-5A56F85E-93C6-433F-83C2-2F837B9C6116Q34749877-CE47AB5E-E49B-4CEE-AC20-860EA7BA308AQ34864372-9BA38397-9A6B-4EE6-A658-1353FF69B4A8Q34999872-6A50D3F5-6DAF-4668-98A1-778A76BD5701Q35423428-E2E03E73-D934-48A4-A771-1BE18B286812Q35506528-427EA5AD-005F-4D30-9BC9-50DCE7DAC9F3Q35857161-81784B4F-52B1-4DB2-B953-8CAEA9A29082Q35922527-7004751D-49BC-4D5A-AAEA-CA766CA8AA1DQ35928276-89CD2FEF-76CB-4D9C-93DF-05F48219E80BQ36446460-8CBF808C-2D58-4FD5-B9DC-9992CBD2A7DBQ36656176-080AE5A4-A4AD-4E63-A685-669C83BB303EQ36727308-90C0650B-4EF3-4304-BF66-D6751B29FD3CQ37027508-F7DE4721-6E28-4216-A7CD-F8123BABAB06Q37464765-AF141548-9709-4365-B3BD-06BA7F02410CQ37573393-F4EEF3D5-7DA8-4AC2-960E-18924A26E0A0Q37918803-552E355C-DBF2-4769-B0D7-9FEE769B84F5Q37989143-006752C5-65E8-4D62-923D-8FAED579C670Q38048861-54400278-0567-4B9A-B6A9-4744D13E07DAQ38255071-6712526E-84C6-4BA0-BA34-FD01A727BE21Q38418556-77573391-958C-41EC-A524-2B7CDF772463Q38587362-B0AC53D7-F1C2-429F-AAEA-81C422B0F2D0Q38730769-E8E2684A-349E-48C8-A8FE-F869EF9F97C3Q38897631-A45DFC8B-0E4F-4980-BAB6-70A879445565Q39286948-A331616B-26C9-4655-A41A-565A27361990Q39323923-D0179788-AA51-4B9E-A273-5690B68422C6
P2860
Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.
@ast
Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.
@en
type
label
Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.
@ast
Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.
@en
prefLabel
Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.
@ast
Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.
@en
P2093
P2860
P1433
P1476
Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.
@en
P2093
Ashlee V Moses
Gary Thomas
Janet Douglas
Klaus Früh
Kristine Gouveia
Mandana Mansouri
Patrick P Rose
Robert E Means
P2860
P304
P356
10.1182/BLOOD-2005-11-4404
P407
P577
2006-04-06T00:00:00Z